Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -5.69%5.36B | -2.17%21.8B | -11.92%5.55B | -5.23%4.89B | 5.70%5.68B | 4.37%5.68B | 1.80%22.28B | -11.02%6.31B | -3.69%5.16B | 14.26%5.37B |
| Cost of revenue | -1.95%4.13B | 0.70%16.32B | -10.99%4.16B | -5.24%3.64B | 13.49%4.35B | 9.61%4.22B | -8.48%16.2B | -12.08%4.68B | -9.17%3.85B | -3.42%3.83B |
| Gross profit | -16.42%1.23B | -9.79%5.49B | -14.59%1.39B | -5.21%1.25B | -13.69%1.33B | -8.25%1.47B | 45.25%6.08B | -7.81%1.63B | 16.97%1.31B | 109.94%1.54B |
| Operating expense | -51.33%255.52M | 95.99%1.04B | 77.68%206.52M | 118.03%323.23M | -46.92%57.82M | 238.30%524.95M | 7.91%528.57M | 22.05%116.23M | 16.37%148.25M | -38.87%108.92M |
| Selling and administrative expenses | ---- | 53.05%928.22M | ---- | ---- | ---- | ---- | 28.12%606.49M | ---- | ---- | ---- |
| -General and administrative expense | ---- | 53.05%928.22M | ---- | ---- | ---- | ---- | 28.12%606.49M | ---- | ---- | ---- |
| Other operating expenses | -48.04%291.41M | 97.76%656.42M | 42.72%587.71M | 79.08%367.44M | -15.41%114.84M | 202.06%560.82M | 67.46%331.92M | 272.19%411.81M | 38.35%205.18M | -27.95%135.75M |
| Total other operating income | 0.07%35.89M | 33.88%548.68M | 28.97%381.2M | -22.34%44.22M | 112.53%57.02M | 17.63%35.87M | 125.48%409.84M | 112.65%295.58M | 172.16%56.93M | 161.69%26.83M |
| Operating profit | 3.04%970.16M | -19.86%4.45B | -21.68%1.18B | -20.87%922.84M | -11.16%1.27B | -34.76%941.56M | 50.20%5.55B | -9.51%1.51B | 17.04%1.17B | 157.68%1.43B |
| Net non-operating interest income (expenses) | -3.90%-407.51M | 13.46%-1.55B | 16.10%-337.81M | 9.50%-397.38M | 8.82%-416.45M | 19.44%-392.23M | -12.99%-1.79B | 7.78%-402.62M | -1.44%-439.08M | -20.58%-456.71M |
| Non-operating interest expense | 3.90%407.51M | -13.46%1.55B | -16.10%337.81M | -9.50%397.38M | -8.82%416.45M | -19.44%392.23M | 12.99%1.79B | -7.78%402.62M | 1.44%439.08M | 20.58%456.71M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -15.58%97.46M | 53.00%405.18M | 41.65%67.11M | 19.40%109.78M | 66.07%83.63M | 53.63%115.45M | -20.32%264.82M | -61.54%47.37M | 96.55%91.94M | -36.49%50.36M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -0.70%660.11M | -17.91%3.31B | -21.02%914.09M | -22.45%635.24M | -8.40%938.7M | -35.55%664.78M | 64.64%4.03B | -14.79%1.16B | 34.20%819.16M | 300.41%1.02B |
| Income tax | 13.78%175.37M | 4.52%638.62M | 43.44%182.81M | -7.72%127.06M | 0.57%165.61M | -14.93%154.14M | 46.54%610.99M | -33.51%127.44M | 34.00%137.7M | 152.43%164.66M |
| Net income | -5.07%484.74M | -21.92%2.67B | -29.00%731.28M | -25.43%508.18M | -10.12%773.09M | -39.95%510.64M | 68.35%3.42B | -11.71%1.03B | 34.24%681.47M | 351.02%860.16M |
| Net income continuous operations | -5.07%484.74M | -21.92%2.67B | -29.00%731.28M | -25.43%508.18M | -10.12%773.09M | -39.95%510.64M | 68.35%3.42B | -11.71%1.03B | 34.24%681.47M | 351.02%860.16M |
| Noncontrolling interests | -139.52%-15.83M | 709.01%126.38M | 297.61%61.29M | 208.97%18.77M | -64.10%5.4M | 1,573.38%40.04M | 239.88%15.62M | -49.22%15.41M | -43.57%-17.22M | 285.41%15.04M |
| Net income attributable to the company | 6.37%500.57M | -25.27%2.55B | -33.96%670M | -29.95%489.41M | -9.16%767.69M | -44.50%470.6M | 67.96%3.41B | -10.71%1.01B | 34.46%698.69M | 325.06%845.12M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 6.37%500.57M | -25.27%2.55B | -33.96%670M | -29.95%489.41M | -9.16%767.69M | -44.50%470.6M | 67.96%3.41B | -10.71%1.01B | 34.46%698.69M | 325.06%845.12M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 2.09%0.0586 | -26.25%0.3096 | -35.34%0.0805 | -30.16%0.0602 | -10.35%0.0935 | -45.18%0.0574 | 67.72%0.4198 | -11.20%0.1245 | 34.48%0.0862 | 325.71%0.1043 |
| Diluted earnings per share | -3.35%0.0548 | -29.96%0.2903 | -38.44%0.0756 | -29.30%0.0596 | -9.59%0.0924 | -44.79%0.0567 | 67.54%0.4145 | -11.14%0.1228 | 32.55%0.0843 | 318.85%0.1022 |
| Dividend per share | 0.04 | 23.08%0.08 | 33.33%0.04 | 0 | 14.29%0.04 | 0 | 30.00%0.065 | 20.00%0.03 | 0 | 40.00%0.035 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.